Adherence to a Six-Week Study of Wearable Digital Mood and Cognitive Assessments in Depression

At the 2021 SOBP Annual Meeting, our Director of Research & Innovation, Francesca Cormack hosted an interactive poster session on Adherence to a Six-Week Study of Wearable Digital Mood and Cognitive Assessments in Depression: Qualitative Insight

Read on for the key findings and full poster.

Lessons learned delivering virtual trials during Covid-19

Digital health expert Dr Jordan Brayanov from Takeda Pharmaceuticals shares his lessons learned delivering virtual trials during Covid-19 and predictions on what’s next for the industry.

Digital Health Event 2020 | Key takeaways from the industry experts

Industry experts working at the forefront of drug development, devices and digital health shared their lessons learned delivering virtual trials during the Covid-19 pandemic at Cambridge Cognition’s fourth annual Digital Health Event. Catch up on the key takeways from this thought-leading discussion. 

Automated administration of Serial Subtraction in a remote data collection context: novel timing fea

New research presented at CTAD 2020 reports the successful derivation of novel measures of timing for a more nuanced assessment of performance on the Serial Subtraction task. 

Four reasons to use digital health in your clinical trials

In the first of our digital health series we will outline what the term means, and the opportunities offered, within the context of clinical trials in psychiatry. 

New client signs with Cognition Kit software

We’re delighted to announce a new $0.5m contract with a major pharmaceutical company for the use of our Cognition Kit digital health software in a clinical trial.

Cognition Kit wearable technology demonstrates high compliance among patients with major depressive

​At the 2017 International CNS Summit in Boca Raton, Florida, we were pleased to release the positive results from a pilot study into the evaluation of cognition and mood using wearable technology in patients with MDD.

Join us at the CNS Summit 2017

Cambridge Cognition are attending the Collaborating for Novel Solutions (CNS) Summit: 16th-19th November 2017. 

Feasibility of automated voice based cognitive assessment on a consumer voice platform

Exploring the use of automated voice based cognitive assessments on consumer voice platforms.

What is test-retest reliability and why is it important?

Digital Health & Innovation Scientist, Matthew Hobbs explores what test re-test reliability is, how you would measure it and why it is important when choosing cognitive tests.